Search - tctmd.com

Displaying 461 - 480 of 706

Sort: Relevancy | Date

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

Shelley Wood

May 26, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

News Conference News EuroPCR 2019

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Shelley Wood

May 21, 2019

News Daily News

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Michael O'Riordan

May 06, 2019

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2019

Shelley Wood

March 29, 2019

Presentation ACC 2019

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

Presenter: Adam D. DeVore

March 17, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Yael L. Maxwell

February 28, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

News Daily News

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Todd Neale

February 01, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

Shelley Wood

December 31, 2018

News Features

Year in Review: Physicians Pick the Biggest News of 2018

TCTMD News Team

December 29, 2018

News Daily News

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

L.A. McKeown

December 21, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Caitlin E. Cox

November 13, 2018

Advertisement

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

TCTMD’s Top 10 Most Popular Stories for March 2019

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

One in Two Americans Have Cardiovascular Disease: AHA Stats

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

TCTMD’s Top 10 Most Popular Stories for December 2018

The Biggest News of 2018: TCTMD’s Top 10

Year in Review: Physicians Pick the Biggest News of 2018

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content